First comprehensive characterization of a Mycolicibacterium clinical isolate from sputum: antibiotic susceptibility, biochemical profile, and genomic features

A putative novel rapidly growing Mycolicibacterium , designated Mycolicibacterium sp. strain NIID-NTM18-2, was first isolated in China from the sputum of a 60-year-old man suspected of lung cancer. Whole-genome sequencing (WGS) revealed an average nucleotide identity (ANI) of 99.7% between this strain and strain NIID-NTM18 previously isolated from a cardiac implantable electronic device in Japan, while showing only 88.27% ANI to its closest type strain, Mycolicibacterium litorale , suggesting that NIID-NTM18-2 and NIID-NTM18 may represent a novel species within the genus Mycolicibacterium . This is the first reported isolation of this species from sputum; furthermore, substantial genomic differences were observed between the two isolates. Additionally, we provide the first description of its fatty acid profile, biochemical reactions, and antibiotic susceptibility patterns. This comprehensive dataset provides critical evidence for accurate taxonomic classification, enhances epidemiological surveillance, and informs potential clinical management strategies.

Authors

Institutions

Publication Details

Journal
BMC Microbiology
Published
2026-11-19
DOI
https://doi.org/10.1186/s12866-026-05763-5
Primary Topic
Mycobacterium research and diagnosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

First comprehensive characterization of a Mycolicibacterium clinical isolate from sputum: antibiotic susceptibility, biochemical profile, and genomic features

Xi Lin, Yuling Xiao, Yu Feng, Dan Zhou et al.
BMC Microbiology
Mycobacterium research and diagnosis
article

First comprehensive characterization of a Mycolicibacterium clinical isolate from sputum: antibiotic susceptibility, biochemical profile, and genomic features

Xi Lin, Yuling Xiao, Yu Feng, Dan Zhou, Ziyang Jiang
article en

Abstract

A putative novel rapidly growing Mycolicibacterium , designated Mycolicibacterium sp. strain NIID-NTM18-2, was first isolated in China from the sputum of a 60-year-old man suspected of lung cancer. Whole-genome sequencing (WGS) revealed an average nucleotide identity (ANI) of 99.7% between this strain and strain NIID-NTM18 previously isolated from a cardiac implantable electronic device in Japan, while showing only 88.27% ANI to its closest type strain, Mycolicibacterium litorale , suggesting that NIID-NTM18-2 and NIID-NTM18 may represent a novel species within the genus Mycolicibacterium . This is the first reported isolation of this species from sputum; furthermore, substantial genomic differences were observed between the two isolates. Additionally, we provide the first description of its fatty acid profile, biochemical reactions, and antibiotic susceptibility patterns. This comprehensive dataset provides critical evidence for accurate taxonomic classification, enhances epidemiological surveillance, and informs potential clinical management strategies.

BMC Microbiology
Sichuan University (CN), West China Hospital of Sichuan University (CN), Sichuan Research Center of New Materials (CN)
Mycobacterium research and diagnosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon